NDAINJECTIONINJECTABLE
Approved
Feb 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TECHNETIUM TC-99M MEDRONATE KIT (technetium tc 99m medronate) by R-Pharm US is radiopharmaceutical activity [moa]. First approved in 1981.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Technetium TC-99M Medronate is a radioactive diagnostic agent used for bone imaging and scintigraphy to detect skeletal abnormalities, infections, and metabolic bone disease. The radiopharmaceutical localizes to areas of increased osteogenic activity through a mechanism of bone uptake and redistribution. It is administered via intravenous injection for diagnostic imaging procedures.
LOE Approaching
Mature diagnostic product nearing loss of exclusivity with low competitive pressure (30%), likely a stable but declining revenue contributor with smaller specialized teams.
Mechanism of Action
Radiopharmaceutical Activity
Pharmacologic Class:
Radioactive Diagnostic Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Technetium TC-99M Medronate offers exposure to nuclear medicine and diagnostic imaging sectors, though with limited growth opportunity given the mature lifecycle stage. Career progression may be constrained by the approaching loss of exclusivity, making this suitable for professionals seeking stable, specialized diagnostic expertise rather than rapid advancement.
Diagnostic Product Manager
Worked on TECHNETIUM TC-99M MEDRONATE KIT at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.